Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Operating Leases (2020 - 2025)

Historic Operating Leases for Neuroone Medical Technologies (NMTC) over the last 6 years, with Q4 2025 value amounting to $110374.0.

  • Neuroone Medical Technologies' Operating Leases fell 5350.27% to $110374.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $110374.0, marking a year-over-year decrease of 5350.27%. This contributed to the annual value of $143148.0 for FY2025, which is 2636.12% down from last year.
  • Per Neuroone Medical Technologies' latest filing, its Operating Leases stood at $110374.0 for Q4 2025, which was down 5350.27% from $143148.0 recorded in Q3 2025.
  • Neuroone Medical Technologies' 5-year Operating Leases high stood at $315673.0 for Q3 2021, and its period low was $20982.0 during Q4 2023.
  • For the 5-year period, Neuroone Medical Technologies' Operating Leases averaged around $214055.3, with its median value being $214482.0 (2023).
  • In the last 5 years, Neuroone Medical Technologies' Operating Leases plummeted by 9229.75% in 2023 and then surged by 103133.64% in 2024.
  • Over the past 5 years, Neuroone Medical Technologies' Operating Leases (Quarter) stood at $288388.0 in 2021, then fell by 5.54% to $272405.0 in 2022, then tumbled by 92.3% to $20982.0 in 2023, then soared by 1031.34% to $237377.0 in 2024, then tumbled by 53.5% to $110374.0 in 2025.
  • Its Operating Leases stands at $110374.0 for Q4 2025, versus $143148.0 for Q3 2025 and $175344.0 for Q2 2025.